Zobrazeno 1 - 6
of 6
pro vyhledávání: '"A61K2039/522"'
Autor:
Virginia Tech Intellectual Properties, Inc., Rathore, Dharmendar, Jani, Dewal, Nagarkatti, Rana
A novel Fasciclin Related Adhesive Protein (FRAP) from Plasmodium and related parasites is provided as a target for therapeutic intervention in diseases caused by the parasites. FRAP has been shown to play a critical role in adhesion to, or invasion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2485::0a9e5da28463a36989de6f6219ca2054
https://hdl.handle.net/10919/72592
https://hdl.handle.net/10919/72592
Autor:
Virginia Tech Intellectual Properties, Inc., Boyle, Stephen M., Schurig, Gerhardt G., Sriranganathan, Nammalwar, Bandara, Aloka B.
A recombinant, attenuated strain of Brucella suis or Brucella melitensis with a deficiency in carboxyl-terminal protease activity or tail-specific protease activity can be used as a vaccine for the prevention or treatment of Brucellosis. Prior exposu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2485::bd43483744534eb02ce6f0a6f3dfee15
http://pimg-fpiw.uspto.gov/fdd/45/647/073/0.pdf
http://pimg-fpiw.uspto.gov/fdd/45/647/073/0.pdf
Autor:
The Regents of the University of California, Virginia Tech Intellectual Properties, Inc., Boyle, Stephen M., Cravero, Silvio, Corbeil, Lynette B., Schurig, Gerhardt G., Srirnaganathan, Nammalwar, Vemulapalli, Ramesh
This invention relates to an over-expressing homologous antigen vaccine, a method of producing the same, and use of the vaccine for prophylaxis or treatment of vertebrates at risk of or suffering from disease caused by a pathogenic micro-organism. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2485::de3e6bd77b1b468119604b14536bc618
https://hdl.handle.net/10919/72500
https://hdl.handle.net/10919/72500
Autor:
Virginia Tech Intellectual Properties, Inc., Inzana, Thomas J., Ward, Christine
Vaccines for diseases caused by normally encapsulated organisms are produced by genetically modifying those organisms by deleting the genes encoding for capsule synthesis or a portion thereof sufficient to produce non-capsulated mutants of the organi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2485::d5a96c337b6728d08ae9f664fb789e49
https://hdl.handle.net/10919/72442
https://hdl.handle.net/10919/72442
Autor:
The Regents of the University of California, Virginia Tech Intellectual Properties, Inc., Boyle, Stephen M., Cravero, Silvio, Corbeil, Lynette B., Schurig, Gerhardt G., Srirnaganathan, Nammalwar, Vemulapalli, Ramesh
This invention relates to an over-expressing homologous antigen vaccine, a method of producing the same, and use of the vaccine for prophylaxis or treatment of vertebrates at risk of or suffering from disease caused by a pathogenic micro-organism. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2485::d88ddd30e30a79a4886f485da86e9c29
https://hdl.handle.net/10919/72428
https://hdl.handle.net/10919/72428
Autor:
Virginia Tech Intellectual Properties, Inc., Inzana, Thomas J., Ward, Christine
Vaccines for diseases caused by normally encapsulated organisms are produced by genetically modifying those organisms by deleting the genes encoding for capsule synthesis or a portion thereof sufficient to produce non-capsulated mutants of the organi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2485::63a060925b6764f4fc30ace02b168462
http://pimg-fpiw.uspto.gov/fdd/94/868/060/0.pdf
http://pimg-fpiw.uspto.gov/fdd/94/868/060/0.pdf